This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.

How to buy Ampio Pharmaceuticals stock | $1.07

Own Ampio Pharmaceuticals stock in just a few minutes.

Posted

Fact checked

Ampio Pharmaceuticals, Inc is a biotechnology business based in the US. Ampio Pharmaceuticals shares (AMPE) are listed on the NYSE and all prices are listed in US Dollars. Ampio Pharmaceuticals employs 23 staff and has a market cap (total outstanding shares value) of USD$144.9 million.

How to buy shares in Ampio Pharmaceuticals

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Ampio Pharmaceuticals. Find the stock by name or ticker symbol: AMPE. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Ampio Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$1.07, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Ampio Pharmaceuticals, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Ampio Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Ampio Pharmaceuticals share price

Use our graph to track the performance of AMPE stocks over time.

Ampio Pharmaceuticals shares at a glance

Information last updated 2020-10-20.
Latest market close USD$1.07
52-week range USD$0.26 - USD$1.24
50-day moving average USD$0.8447
200-day moving average USD$0.7076
Wall St. target price USD$4.5
PE ratio 26.8714
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.014

Buy Ampio Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Ampio Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ampio Pharmaceuticals price performance over time

Historical closes compared with the close of $1.07 from 2020-12-04

1 week (2020-11-25) 22.99%
1 month (2020-11-05) 21.59%
3 months (2020-09-04) 50.70%
6 months (2020-06-05) 105.77%
1 year (2019-12-05) 149.71%
2 years (2018-12-04) 64.59%
3 years (2017-12-05) -37.79%
5 years (2015-12-04) -68.71%

Is Ampio Pharmaceuticals under- or over-valued?

Valuing Ampio Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ampio Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ampio Pharmaceuticals's P/E ratio

Ampio Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, Ampio Pharmaceuticals shares trade at around 27x recent earnings.

That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).

Ampio Pharmaceuticals financials

Gross profit TTM USD$0
Return on assets TTM -79.92%
Return on equity TTM -185.05%
Profit margin 0%
Book value $0.037
Market capitalisation USD$144.9 million

TTM: trailing 12 months

Shorting Ampio Pharmaceuticals shares

There are currently 17.9 million Ampio Pharmaceuticals shares held short by investors – that's known as Ampio Pharmaceuticals's "short interest". This figure is 12.6% up from 15.9 million last month.

There are a few different ways that this level of interest in shorting Ampio Pharmaceuticals shares can be evaluated.

Ampio Pharmaceuticals's "short interest ratio" (SIR)

Ampio Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Ampio Pharmaceuticals shares currently shorted divided by the average quantity of Ampio Pharmaceuticals shares traded daily (recently around 5.7 million). Ampio Pharmaceuticals's SIR currently stands at 3.13. In other words for every 100,000 Ampio Pharmaceuticals shares traded daily on the market, roughly 3130 shares are currently held short.

However Ampio Pharmaceuticals's short interest can also be evaluated against the total number of Ampio Pharmaceuticals shares, or, against the total number of tradable Ampio Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ampio Pharmaceuticals's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Ampio Pharmaceuticals shares in existence, roughly 100 shares are currently held short) or 0.1027% of the tradable shares (for every 100,000 tradable Ampio Pharmaceuticals shares, roughly 103 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ampio Pharmaceuticals.

Find out more about how you can short Ampio Pharmaceuticals stock.

Ampio Pharmaceuticals share dividends

We're not expecting Ampio Pharmaceuticals to pay a dividend over the next 12 months.

Have Ampio Pharmaceuticals's shares ever split?

Ampio Pharmaceuticals's shares were split on a 1:3 basis on 1 August 2008. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ampio Pharmaceuticals shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Ampio Pharmaceuticals shares which in turn could have impacted Ampio Pharmaceuticals's share price.

Ampio Pharmaceuticals share price volatility

Over the last 12 months, Ampio Pharmaceuticals's shares have ranged in value from as little as $0.26 up to $1.24. A popular way to gauge a stock's volatility is its "beta".

AMPE.US volatility(beta: 1.75)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Ampio Pharmaceuticals's is 1.7534. This would suggest that Ampio Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Ampio Pharmaceuticals overview

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. It is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. The company's product pipeline includes Ampion, which is in phase III clinical trial, is an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site